Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Rituximab For Refractory Polymyositis: An Open-label Prospective Study.


  • Please log in to reply
No replies to this topic

#1 Guest_Jude the Grouch_*

Guest_Jude the Grouch_*
  • Guests

Posted 06 September 2007 - 08:04 AM

Rituximab For Refractory Polymyositis: An Open-Label Prospective Study. Rituximab is an option to be considered in refractory polymyositis and further controlled trials are necessary to confirm its efficacy. C. C. Mok THU0292 EULAR 2007. (Also see: Polymyositis)